Spantler, D.; Csecsei, P.; Borocz, K.; Berki, T.; Zavori, L.; Schwarcz, A.; Lenzser, G.; Molnar, T.
Serum Periostin May Help to Identify Patients with Poor Collaterals in the Hyperacute Phase of Ischemic Stroke. Diagnostics 2022, 12, 1942.
https://doi.org/10.3390/diagnostics12081942
AMA Style
Spantler D, Csecsei P, Borocz K, Berki T, Zavori L, Schwarcz A, Lenzser G, Molnar T.
Serum Periostin May Help to Identify Patients with Poor Collaterals in the Hyperacute Phase of Ischemic Stroke. Diagnostics. 2022; 12(8):1942.
https://doi.org/10.3390/diagnostics12081942
Chicago/Turabian Style
Spantler, Dora, Peter Csecsei, Katalin Borocz, Timea Berki, Laszlo Zavori, Attila Schwarcz, Gabor Lenzser, and Tihamer Molnar.
2022. "Serum Periostin May Help to Identify Patients with Poor Collaterals in the Hyperacute Phase of Ischemic Stroke" Diagnostics 12, no. 8: 1942.
https://doi.org/10.3390/diagnostics12081942
APA Style
Spantler, D., Csecsei, P., Borocz, K., Berki, T., Zavori, L., Schwarcz, A., Lenzser, G., & Molnar, T.
(2022). Serum Periostin May Help to Identify Patients with Poor Collaterals in the Hyperacute Phase of Ischemic Stroke. Diagnostics, 12(8), 1942.
https://doi.org/10.3390/diagnostics12081942
